Polus Tech develops and commercializes communication-based homeland security and public safety products. Polus Tech was founded together with Israel Aerospace Industries Ltd., the commercial vehicle of the Israeli Airforce. Polus Tech’s products can be used for various situations such as tactical and network-based intelligence solutions for mobile device cyber intelligence, and as detection and communication tools for first responders, in search & rescue scenarios.
Ayala Pharmaceuticals focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers which are identified as having an aberrant activation of the Notch pathway. Such activation has long been implicated in multiple solid tumor and blood-related cancers and has often been associated with more aggressive cancers. In January 2023, Ayala Pharmaceuticals completed a merger with Advaxis, Inc., a public biotech company (ADXS).